These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33653703)

  • 1. Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction.
    Straw S; McGinlay M; Witte KK
    Open Heart; 2021 Mar; 8(1):. PubMed ID: 33653703
    [No Abstract]   [Full Text] [Related]  

  • 2. [How to evaluate and treat heart failure with preserved left ventricular ejection fraction].
    Cohen Solal A; Tournoux F; Beauvais F; Tartiere JM
    Therapie; 2009; 64(2):101-9. PubMed ID: 19664403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind placebo-controlled trial of perhexiline in heart failure with preserved ejection fraction syndrome.
    Singh S; Beadle R; Cameron D; Rudd A; Bruce M; Jagpal B; Schwarz K; Brindley G; Mckiddie F; Lang C; Dawson D; Frenneaux M
    Future Cardiol; 2014 Nov; 10(6):693-8. PubMed ID: 25495811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Conundrum of Patient Selection in Trials of Heart Failure With Preserved Ejection Fraction: Exploring the Benefits and Risks of Focused Phenotyping.
    Plehn JF
    J Card Fail; 2017 Jul; 23(7):525-527. PubMed ID: 28545949
    [No Abstract]   [Full Text] [Related]  

  • 5. Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Otto CM
    Heart; 2018 Mar; 104(5):361-362. PubMed ID: 29440452
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of heart rate control in chronic heart failure with reduced ejection fraction.
    Grande D; Iacoviello M; Aspromonte N
    Heart Fail Rev; 2018 Jul; 23(4):527-535. PubMed ID: 29687317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 2015 Jan; 57(1460):9-13. PubMed ID: 25581106
    [No Abstract]   [Full Text] [Related]  

  • 8. Targets for Heart Failure With Preserved Ejection Fraction.
    Nanayakkara S; Kaye DM
    Clin Pharmacol Ther; 2017 Aug; 102(2):228-237. PubMed ID: 28466986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
    Fiuzat M; Hamo CE; Butler J; Abraham WT; DeFilippis EM; Fonarow GC; Lindenfeld J; Mentz RJ; Psotka MA; Solomon SD; Teerlink JR; Vaduganathan M; Vardeny O; McMurray JJV; O'Connor CM
    J Am Coll Cardiol; 2022 Feb; 79(5):504-510. PubMed ID: 35115106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.
    Ibrahim NE; Piña IL; Camacho A; Bapat D; Felker GM; Maisel AS; Butler J; Prescott MF; Abbas CA; Solomon SD; Januzzi JL;
    Circ Heart Fail; 2020 Nov; 13(11):e007829. PubMed ID: 33016100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Nguyen E; Weeda ER; White CM
    J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Zheng SL; Chan FT; Nabeebaccus AA; Shah AM; McDonagh T; Okonko DO; Ayis S
    Heart; 2018 Mar; 104(5):407-415. PubMed ID: 28780577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.
    Finch KT; Stratton EA; Farber HW
    J Heart Lung Transplant; 2016 Nov; 35(11):1370-1373. PubMed ID: 27623099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaceutical Treatment Options in Heart Failure with Preserved Ejection Fraction].
    Trippel TD; Tschöpe C
    Dtsch Med Wochenschr; 2020 Sep; 145(19):1377-1383. PubMed ID: 32971552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Novel Treatment Approaches for Heart Failure With Reduced Ejection Fraction.
    Patel S; Veltri K
    J Pharm Pract; 2017 Oct; 30(5):541-548. PubMed ID: 27194070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies.
    Vaduganathan M; Butler J; Pitt B; Gheorghiade M
    Circ Heart Fail; 2015 Jul; 8(4):826-31. PubMed ID: 26199309
    [No Abstract]   [Full Text] [Related]  

  • 17. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction.
    Kim MN; Park SM
    Heart Fail Clin; 2021 Jul; 17(3):463-482. PubMed ID: 34051977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse Remodeling and Current Medical Therapy in Heart Failure with Reduced Ejection Fraction.
    Maki H; Takeda N
    Int Heart J; 2020; 61(2):197-198. PubMed ID: 32224600
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.
    Holland DJ; Kumbhani DJ; Ahmed SH; Marwick TH
    J Am Coll Cardiol; 2011 Apr; 57(16):1676-86. PubMed ID: 21492765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure.
    Veenis JF; Brunner-La Rocca HP; Linssen GCM; Van Gent MWF; Hoes AW; Brugts JJ;
    Circ Heart Fail; 2020 May; 13(5):e006667. PubMed ID: 32370547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.